Case Study

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

Certara2025 年 10 月 2 日

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara2025 年 9 月 22 日

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

Certara2025 年 9 月 22 日

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…

Certara2025 年 9 月 17 日

Blog

制定 EMA 政策0070 提交材料的常见问题解答

This blog answers audience questions posed during our RAPS webinar, How to Plan for a…

Certara2025 年 9 月 15 日

Guide

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…

Certara2025 年 9 月 11 日

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle Pillsbury2025 年 9 月 10 日

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

Certara2025 年 9 月 9 日

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

Certara2025 年 9 月 5 日

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

Certara2025 年 9 月 5 日

药物开发